Active monomers of human beta-tryptase have expanded substrate specificities

Area of Science:

• Biochemistry
• Immunology
• Cell Biology

Background:

• Beta-tryptase is a serine protease found in human mast cells, released upon activation.
• Its unique homotetrameric structure, stabilized by heparin, confers resistance to inhibitors.
• Elevated tryptase levels are observed in asthma and anaphylaxis, suggesting a role in inflammation.

Purpose of the Study:

• To discuss the identification of enzymatically active beta-tryptase monomers.
• To explore the potential in vivo role of these monomers.

Main Methods:

• Review of existing literature on beta-tryptase structure, function, and detection.
• Discussion of in vitro studies identifying active beta-tryptase monomers.

Main Results:

• Beta-tryptase exists in a stable homotetrameric form but can convert to inactive monomers at neutral pH without stabilization.
• Enzymatically active beta-tryptase monomers have been detected in vitro.
• Beta-tryptase degrades various substrates, including fibrinogen, fibronectin, and PAR2.

Conclusions:

• Active beta-tryptase monomers represent a newly identified form of the enzyme.
• These monomers may play a significant role in the in vivo functions and pathology associated with beta-tryptase.
• Further research is needed to elucidate the precise in vivo functions of beta-tryptase monomers.